Odyssey Therapeutics Inc
ODTX
NASDAQ
Biotechnology
$20.73
USD
+0.01 (+0.05%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.07B
Volume 136.3K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2026 |
|---|---|
Revenue | 0.0 |
YoY Growth | — |
Cost of Revenue | 0.0 |
Gross Profit | 0.0 |
Selling, General & Administrative | 10.5 |
Other Operating Expenses | 8.7 |
Total Operating Expenses | 55.5 |
Operating Income | -55.5 |
EBITDA | -54.4 |
Other Income / Expense | -0.1 |
Total Other Income / Expense | 2.7 |
Income Before Income Taxes | -52.8 |
Income Taxes | -0.0 |
Net Income | -52.8 |
Consolidated Net Income / Loss | -52.8 |
Net Income Attributable to Common Shareholders | -52.8 |
Basic EPS | -$1.74 |
Diluted EPS | -$1.74 |
Basic Shares Outstanding | 30.3M |
Diluted Shares Outstanding | 30.3M |